Breakthrough Therapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
REGN | A | Regeneron Pharmaceuticals, Inc. | 0.57 | |
VRTX | B | Vertex Pharmaceuticals Incorporated | 0.54 | |
ASND | C | Ascendis Pharma A/S | -1.76 | |
HUMA | D | Humacyte, Inc. | 11.88 | |
PROK | D | ProKidney Corp. | 1.63 | |
GYRE | F | Gyre Therapeutics, Inc. | 0.92 | |
TSVT | F | 2seventy bio, Inc. | 5.19 | |
CMPS | F | COMPASS Pathways Plc | -1.49 | |
ACHL | F | Achilles Therapeutics plc | -1.60 | |
PPBT | F | Purple Biotech Ltd. | -11.77 |
Related Industries: Biotechnology Long-Term Care Facilities Medical Care Facilities
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MEDI | C | Harbor Health Care ETF | 17.84 | |
PSIL | F | AdvisorShares Psychedelics ETF | 6.24 | |
CNCR | D | Loncar Cancer Immunotherapy ETF | 3.27 | |
FBT | B | First Trust Amex Biotech Index Fund | 2.76 | |
IBB | B | iShares Nasdaq Biotechnology Index Fund | 2.19 |
Compare ETFs
- Breakthrough Therapy
Breakthrough therapy is a United States Food and Drug Administration designation that expedites drug development that was created by Congress under Section 902 of the 9 July 2012 Food and Drug Administration Safety and Innovation Act. The FDA's "breakthrough therapy" designation is not intended to imply that a drug is actually a "breakthrough" or that there is high-quality evidence of treatment efficacy for a particular condition; rather, it allows the FDA to grant priority review to drug candidates if preliminary clinical trials indicate that the therapy may offer substantial treatment advantages over existing options for patients with serious or life-threatening diseases. The FDA has other mechanisms for expediting the review and approval process for promising drugs, including fast track designation, accelerated approval, and priority review.
Popular Now
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles